全文获取类型
收费全文 | 1234篇 |
免费 | 85篇 |
国内免费 | 2篇 |
专业分类
耳鼻咽喉 | 16篇 |
儿科学 | 13篇 |
妇产科学 | 13篇 |
基础医学 | 207篇 |
口腔科学 | 132篇 |
临床医学 | 69篇 |
内科学 | 223篇 |
皮肤病学 | 64篇 |
神经病学 | 171篇 |
特种医学 | 22篇 |
外科学 | 101篇 |
综合类 | 4篇 |
预防医学 | 108篇 |
眼科学 | 28篇 |
药学 | 75篇 |
中国医学 | 16篇 |
肿瘤学 | 59篇 |
出版年
2024年 | 1篇 |
2023年 | 14篇 |
2022年 | 29篇 |
2021年 | 45篇 |
2020年 | 22篇 |
2019年 | 32篇 |
2018年 | 50篇 |
2017年 | 32篇 |
2016年 | 36篇 |
2015年 | 34篇 |
2014年 | 54篇 |
2013年 | 70篇 |
2012年 | 117篇 |
2011年 | 135篇 |
2010年 | 58篇 |
2009年 | 57篇 |
2008年 | 80篇 |
2007年 | 87篇 |
2006年 | 79篇 |
2005年 | 70篇 |
2004年 | 75篇 |
2003年 | 51篇 |
2002年 | 44篇 |
2001年 | 10篇 |
2000年 | 2篇 |
1999年 | 5篇 |
1998年 | 7篇 |
1997年 | 4篇 |
1996年 | 2篇 |
1995年 | 1篇 |
1994年 | 3篇 |
1993年 | 1篇 |
1992年 | 2篇 |
1991年 | 2篇 |
1990年 | 2篇 |
1988年 | 2篇 |
1987年 | 1篇 |
1983年 | 1篇 |
1974年 | 2篇 |
1971年 | 1篇 |
1969年 | 1篇 |
排序方式: 共有1321条查询结果,搜索用时 15 毫秒
1.
Iclea Rocha Gama Euclides Marinho Trindade-Filho Suzana Lima Oliveira Nassib Bezerra Bueno Isabelle Tenório Melo Cyro Rego Cabral-Junior Elenita M. Barros Jaqueline A. Galvão Wanessa S. Pereira Raphaela C. Ferreira Bruna R. Domingos Terezinha da Rocha Ataide 《Metabolic brain disease》2015,30(1):93-98
2.
3.
Ethanol-Induced Enhancement of Cocaine Bioactivation and Irreversible Protein Binding: Evidence Against a Role of Cytochrome P-450IIE1 总被引:1,自引:0,他引:1
Urs A. Boelsterli Suzana Atanasoski Christian Göldlin 《Alcoholism, clinical and experimental research》1991,15(5):779-784
Chronic ethanol consumption potentiates cocaine-induced liver injury in rodents. Since cocaine has to be bioactivated by a cytochrome P-450-dependent N-oxidative pathway to exert its hepatotoxic effects, we studied the role of the ethanol-inducible P-450IIE1 for cocaine metabolism. Male Sprague-Dawley rats were pretreated with either a liquid diet containing ethanol (30% of calories) for 4 weeks or injected with pyrazole (200 mg/kg/day, ip, for 3 days). Both agents induced microsomal p-nitrophenol hydroxylation which is a probe for the catalytic activity of P-450IIE1. However, only ethanol, but not pyrazole, increased both microsomal cocaine N-demethylase activity (by 47%) and the extent of irreversible binding of [3H]-cocaine to microsomal proteins (by 100%), which was taken as a quantitative endpoint for the formation of a reactive metabolite. Cocaine N-demethylation and irreversible protein binding of cocaine were not inhibited by P-450IIE1 isozyme-selective substrates, nor was the rate of cocaine metabolism and binding decreased by functionally active polyclonal anti-rat P-450IIE1 antibodies. Furthermore, pyrazole pretreatment sensitized cultured hepatocytes to the glutathione-dependent cytotoxic effects of nontoxic concentrations of cocaine. These results indicate that (a) cocaine is not a major substrate for the ethanol-inducible P-450IIE1, (b) the enhancing effects of ethanol on cocaine bioactivation may be due to induction of other P-450 isoforms, and (c) induction of P-450IIE1 may potentiate cocaine-induced hepatocellular toxicity in vitro independently of cocaine metabolism, e.g., by P-450IIE1-dependent oxidative stress. 相似文献
4.
Recombinant cysteine proteinase from Leishmania (Leishmania) chagasi implicated in human and dog T-cell responses
下载免费PDF全文
![点击此处可从《Infection and immunity》网站下载免费的PDF全文](/ch/ext_images/free.gif)
da Costa Pinheiro PH de Souza Dias S Eulálio KD Mendonça IL Katz S Barbiéri CL 《Infection and immunity》2005,73(6):3787-3789
High in vitro lymphoproliferative responses were induced in humans and dogs by a recombinant Leishmania (Leishmania) chagasi cysteine proteinase, with secretion of IFN-gamma in asymptomatic subjects or of IFN-gamma, interleukin 4 (IL-4), and IL-10 in oligosymptomatic subjects. In contrast, responses of symptomatic patients and dogs were lower, with production of IL-4 and IL-10. 相似文献
5.
Bruno Guedes Baldi Alexandre Todorovic Fabro Andreia Craveiro Franco Marília Helena C Machado Robson Aparecido Prudente Estefnia Thom Franco Sergio Ribeiro Marrone Simone Alves do Vale Talita Jacon Cezare Marcelo Padovani de Toledo Moraes Eloara Vieira Machado Ferreira Andr Luis Pereira Albuquerque Marcio Valente Yamada Sawamura Suzana Erico Tanni 《Jornal brasileiro de pneumologia》2022,48(3)
6.
Gwendlyn Kollmorgen Gerhard Niederfellner Alexander Lifke Gloria J. Spohn Natascha Rieder Suzana Vega Harring Frieder Bauss Helmut Burtscher Reiner Lammers Birgit Bossenmaier 《Molecular oncology》2013,7(6):1142-1151
CUB-domain-containing-protein-1 (CDCP1) is an integral membrane protein whose expression is up-regulated in various cancer types. Although high CDCP1 expression has been correlated with poor prognosis in lung, breast, pancreas, and renal cancer, its functional role in tumor formation or progression is incompletely understood. So far it has remained unclear, whether CDCP1 is a useful target for antibody therapy of cancer and what could be a desired mode of action for a therapeutically useful antibody. To shed light on these questions, we have investigated the cellular effects of a therapeutic antibody candidate (RG7287). In focus formation assays, prolonged RG7287 treatment prevented the loss of contact inhibition caused by co-transformation of NIH3T3 cells with CDCP1 and Src. In a xenograft study, MCF7 cells stably overexpressing CDCP1 reached the predefined tumor volume faster than the parental MCF7 cells lacking endogenous CDCP1. This tumor growth advantage was abolished by RG7287 treatment. In vitro, RG7287 induced rapid tyrosine phosphorylation of CDCP1 by Src, which was accompanied by translocation of CDCP1 to a Triton X-100 insoluble fraction of the plasma membrane. Triggering these effects required bivalency of the antibody suggesting that it involves CDCP1 dimerization or clustering. However, this initial activation of CDCP1 was only transient and prolonged RG7287 treatment induced internalization and down-regulation of CDCP1 in different cancer cell lines. Antibody stimulated CDCP1 degradation required Src activity and was proteasome dependent. Also in three different xenograft models with endogenous CDCP1 expression RG7287 treatment resulted in significant tumor growth inhibition concomitant with substantially reduced CDCP1 levels as judged by immunohistochemistry and Western blotting. Thus, despite transiently activating CDCP1 signaling, the RG7287 antibody has a therapeutically useful mode of action. 相似文献
7.
Alexandre Mendon?a Munhoz Eduardo Montag Rolf Gemperli 《World journal of clinical oncology》2014,5(1):1-18
Breast-conservation surgery (BCS) is established as a safe surgical treatment for most patients with early breast cancer. Recently, advances in oncoplastic techniques are capable of preserving the breast form and quality of life. Although most BCS defects can be managed with primary closure, the aesthetic outcome may be unpredictable. Among technical options, therapeutic reduction mammaplasty (TRM) remains a useful procedure since the BCS defect can be repaired and the preoperative appearance can be improved, resulting in more proportional breasts. As a consequence of rich breast tissue vascularization, the greater part of reduction techniques have based their planning on preserving the pedicle of the nipple-areola complex after tumor removal. Reliable circulation and improvement of a conical shape to the breast are commonly described in TRM reconstructions. With an immediate approach, the surgical process is smooth since both procedures can be carried out in one operative setting. Additionally, it permits wider excision of the tumor, with a superior mean volume of the specimen and potentially reduces the incidence of margin involvement. Regardless of the fact that there is no consensus concerning the best TRM technique, the criteria is determined by the surgeon’s experience, the extent/location of glandular tissue resection and the size of the defect in relation to the size of the remaining breast. The main advantages of the technique utilized should include reproducibility, low interference with the oncological treatment and long-term results. The success of the procedure depends on patient selection, coordinated planning and careful intra-operative management. 相似文献
8.
Prevalence of Sjögren's syndrome in Brazilian patients infected with human T‐cell lymphotropic virus
9.
10.